Brief: Exopharm Says Signs Binding Agreement To Acquire Tryp Therapeutics

Entropy Neurodynamics

08/03/2024 01:29

March 8 (Reuters) - Exopharm  EX1.AX :
    * SIGNS BINDING AGREEMENT TO ACQUIRE TRYP THERAPEUTICS
    * EXOPHARM INTENDS TO RAISE UP TO A$6.5 MILLION VIA A PUBLIC
OFFER
    * UNDERTAKEN INTERIM CAPITAL RAISE BY WAY OF CONVERTIBLE
NOTE OF
A$3.39 MILLION
    * ACQUISITION WILL AMOUNT TO SIGNIFICANT CHANGE TO NATURE
AND
SCALE OF CO'S ACTIVITIES
    * ISSUE PRICE OF A$0.02 PER SHARE FOR PUBLIC OFFER
    * TO RAISE UP TO A$6.5 MILLION TO SUPPORT RESEARCH AND
DEVELOPMENT
OF TRYP'S LEAD PROGRAMS

Source text for Eikon:  ID:nASX6SHf0b 
Further company coverage:  EX1.AX 

 ((Reuters.Briefs@thomsonreuters.com;))